Applied Therapeutics (APLT) Invested Capital (2023 - 2025)
Historic Invested Capital for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$561000.0.
- Applied Therapeutics' Invested Capital fell 10952.14% to -$561000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$561000.0, marking a year-over-year decrease of 10952.14%. This contributed to the annual value of $57.0 million for FY2024, which is 43247.4% up from last year.
- As of Q3 2025, Applied Therapeutics' Invested Capital stood at -$561000.0, which was down 10952.14% from $17.4 million recorded in Q2 2025.
- Applied Therapeutics' Invested Capital's 5-year high stood at $72.4 million during Q2 2024, with a 5-year trough of -$17.1 million in Q4 2023.
- Moreover, its 3-year median value for Invested Capital was $5.9 million (2024), whereas its average is $20.0 million.
- As far as peak fluctuations go, Applied Therapeutics' Invested Capital soared by 177032.76% in 2024, and later plummeted by 10952.14% in 2025.
- Over the past 3 years, Applied Therapeutics' Invested Capital (Quarter) stood at -$17.1 million in 2023, then skyrocketed by 432.47% to $57.0 million in 2024, then tumbled by 100.98% to -$561000.0 in 2025.
- Its Invested Capital stands at -$561000.0 for Q3 2025, versus $17.4 million for Q2 2025 and $36.7 million for Q1 2025.